Basic Information
Interna Therapeutics is an innovative biotechnology company focused on intracellular drug delivery, possessing fully self-developed research facilities across the entire industry chain. The company has established a universal technology platform for intercellular delivery of macromolecular drugs — the Molecular Nano Motor (MNM) technology — developing a unique delivery method capable of transporting DNA, RNA, proteins, peptides, and other macromolecular substances into the cytoplasm. Given the significant benefits of MNM technology, the company places particular emphasis on well-known infectious respiratory viruses such as SARS-CoV-2, influenza, and RSV, as well as chronic respiratory diseases, neurological disorders, and intracellular peptide-drug delivery.
Interna Therapeutics, Ltd.
Israel
15~50 people
--
infointerna@interna.bio

